Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | ALDH1A1 | P00352 | 3/20 | 0.39 |
| ▸ | TSHR | P16473 | 1/20 | 0.37 |
| ▸ | THRB | P10828 | 2/20 | 0.36 |
| ▸ | HTT | P42858 | 2/20 | 0.36 |
| ▸ | MEN1 | O00255 | 1/20 | 0.36 |
| ▸ | KMT2A | Q03164 | 1/20 | 0.36 |
| ▸ | MAPT | P10636 | 1/20 | 0.36 |
| ▸ | CES2 | O00748 | 2/20 | 0.33 |
| ▸ | EPHX2 | P34913 | 1/20 | 0.32 |
| ▸ | TDP1 | Q9NUW8 | 1/20 | 0.31 |
| ▸ | USP2 | O75604 | 1/20 | 0.31 |
| ▸ | CES1 | P23141 | 1/20 | 0.30 |
| ▸ | CA1 | P00915 | 5/20 | 0.30 |
| ▸ | CA2 | P00918 | 5/20 | 0.30 |
| ▸ | CA9 | Q16790 | 5/20 | 0.30 |
| ▸ | CA12 | O43570 | 1/20 | 0.30 |
| ▸ | CA3 | P07451 | 1/20 | 0.30 |
| ▸ | CA4 | P22748 | 1/20 | 0.30 |
| ▸ | CA6 | P23280 | 1/20 | 0.30 |
| ▸ | CA5A | P35218 | 1/20 | 0.30 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL815676 | 1.00 | ALDH1A1 (0.39) | ALDH1A1TSHRTHRBHTTMEN1 | |
| SCHEMBL815873 | 1.00 | ALDH1A1 (0.39) | ALDH1A1TSHRTHRBHTTMEN1 | |
| SCHEMBL817240 | 1.00 | ALDH1A1 (0.39) | ALDH1A1TSHRTHRBHTTMEN1 | |
| SCHEMBL817188 | 1.00 | ALDH1A1 (0.39) | ALDH1A1TSHRTHRBHTTMEN1 | |
| SCHEMBL310698 | 1.00 | ALDH1A1 (0.39) | ALDH1A1TSHRTHRBHTTMEN1 | |
| SCHEMBL815560 | 1.00 | ALDH1A1 (0.39) | ALDH1A1TSHRTHRBHTTMEN1 | |
| SCHEMBL816166 | 1.00 | ALDH1A1 (0.39) | ALDH1A1TSHRTHRBHTTMEN1 | |
| SCHEMBL817195 | 1.00 | ALDH1A1 (0.39) | ALDH1A1TSHRTHRBHTTMEN1 | |
| SCHEMBL815563 | 1.00 | ALDH1A1 (0.39) | ALDH1A1TSHRTHRBHTTMEN1 | |
| SCHEMBL816932 | 1.00 | ALDH1A1 (0.39) | ALDH1A1TSHRTHRBHTTMEN1 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 58 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| CN-118302407-A | Carbonyl compound, method for producing isocyanate compound, and isocyanate composition | 旭化成株式会社 | 2024-07-05 | — | — | CN | disclosed |
| CN-118215651-A | Method for producing isocyanate compound, method for producing urethane compound, method for recovering amine compound, and isocyanate composition | 旭化成株式会社 | 2024-06-18 | — | — | CN | disclosed |
| WO-2024056077-A1 | MODIFIED PROTEINS AND PROTEIN BINDERS AND DEGRADERS | CULLGEN (SHANGHAI) , INC. (CN) | 2024-03-21 | — | — | WO | disclosed |
| WO-2023080257-A1 | METHOD FOR PRODUCING ISOCYANATE COMPOUNDS, METHOD FOR PRODUCING CARBAMATE COMPOUNDS, METHOD FOR RECOVERING AMINE COMPOUNDS, AND ISOCYANATE COMPOSITION | 旭化成株式会社 | 2023-05-11 | — | — | WO | disclosed |
| WO-2023080258-A1 | CARBONYL COMPOUND, METHOD FOR PRODUCING CARBONYL COMPOUND, METHOD FOR PRODUCING ISOCYANATE COMPOUND, AND ISOCYANATE COMPOSITION | 旭化成株式会社 | 2023-05-11 | — | — | WO | disclosed |
| EP-4110772-A1 | TROPOMYOSIN RECEPTOR KINASE (TRK) DEGRADATION COMPOUNDS AND METHODS OF USE | Cullgen (Shanghai), Inc. (CN) | 2023-01-04 | — | — | EP | disclosed |
| WO-2022068933-A1 | COMPOUNDS AND METHODS OF TREATING DISEASES | CULLGEN (SHANGHAI) , INC. (CN) | 2022-04-07 | — | — | WO | disclosed |
| EP-3841098-A1 | TROPOMYOSIN RECEPTOR KINASE (TRK) DEGRADATION COMPOUNDS AND METHODS OF USE | Cullgen (Shanghai), Inc. (CN) | 2021-06-30 | — | — | EP | disclosed |
| WO-2020200291-A1 | COMPOUNDS AND METHODS OF TREATING CANCERS | CULLGEN (SHANGHAI) , INC. (CN) | 2020-10-08 | — | — | WO | disclosed |
| WO-2020038415-A1 | TROPOMYOSIN RECEPTOR KINASE (TRK) DEGRADATION COMPOUNDS AND METHODS OF USE | CULLGEN (SHANGHAI), INC. (CN) | 2020-02-27 | — | — | WO | disclosed |
| WO-2006065844-A2 | PROCESS FOR PRODUCING SUBSTITUTED METALLOCENE COMPOUNDS FOR OLEFIN POLYMERIZATION | EXXONMOBIL CHEMICAL PATENTS INC. (US) | 2006-06-22 | — | — | WO | disclosed |
| EP-1499893-A2 | CHEMICALLY INERT MOLECULAR ALKANE OR OXAALKANE-TAGS AND THEIR IDENTIFICATION BY REACTION WITH FLUOROALKANOYL ACIDS | PHARMACOPEIA, INC. (US) | 2005-01-26 | — | — | EP | disclosed |
| US-20030215871-A1 | Chemically inert molecular tags | PHARMACOPEIA, INC. (US) | 2003-11-20 | — | — | US | disclosed |
| WO-2003093823-A2 | CHEMICALLY INERT MOLECULAR ALKANE OR OXAALKANE-TAGS AND THEIR IDENTIFICATION BY REACTION WITH FLUOROALKANOYL ACIDS | PHARMACOPEIA INC. (US) | 2003-11-13 | — | — | WO | disclosed |
| US-5434202-A | N-(β-carbony- and β-cyanovinyl)-2,2,6,6-tetramethyl-piperidine derivatives | BASF AKTIENGESELLSCHAFT (DE) | 1995-07-18 | — | — | US | disclosed |
| EP-0616610-A1 | N-($g(b)-CARBONYL- AND $g(b)-CYANOVINYL)-2,2,6,6-TETRAMETHYLPIPERIDINE DERIVATIVES AND THEIR USE AS STABILIZERS FOR VARNISHES AND PLASTICS | BASF Aktiengesellschaft (DE) | 1994-09-28 | — | — | EP | disclosed |
| US-5264448-A | Thioamides, oxazole ring, insecticides, miticides | SUMITOMO CHEMICAL COMPANY, LIMITED (JP) | 1993-11-23 | — | — | US | disclosed |
| WO-1993011109-A1 | N-(β-CARBONYL- AND β-CYANOVINYL)-2,2,6,6-TETRAMETHYLPIPERIDINE DERIVATIVES AND THEIR USE AS STABILIZERS FOR VARNISHES AND PLASTICS | BASF AKTIENGESELLSCHAFT (DE) | 1993-06-10 | — | — | WO | disclosed |
| US-5206259-A | Insecticides, acaricides | SUMITOMO CHEMICAL COMPANY, LIMITED (JP) | 1993-04-27 | — | — | US | disclosed |
| EP-0394043-A1 | An amide compound and its production and use | SUMITOMO CHEMICAL COMPANY, LIMITED (JP) | 1990-10-24 | — | — | EP | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20030215871-A1 | Chemically inert molecular tags | ALK, ADH1A, ADH1C | ALDH1A1 20/4885TSHR 684/4885THRB 741/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.